These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 21718508)

  • 1. Left ventricular dysfunction with reduced functional cardiac reserve in diabetic and non-diabetic LDL-receptor deficient apolipoprotein B100-only mice.
    Heinonen SE; Merentie M; Hedman M; Mäkinen PI; Loponen E; Kholová I; Bosch F; Laakso M; Ylä-Herttuala S
    Cardiovasc Diabetol; 2011 Jun; 10():59. PubMed ID: 21718508
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Early development of calcific aortic valve disease and left ventricular hypertrophy in a mouse model of combined dyslipidemia and type 2 diabetes mellitus.
    Le Quang K; Bouchareb R; Lachance D; Laplante MA; El Husseini D; Boulanger MC; Fournier D; Fang XP; Avramoglu RK; Pibarot P; Deshaies Y; Sweeney G; Mathieu P; Marette A
    Arterioscler Thromb Vasc Biol; 2014 Oct; 34(10):2283-91. PubMed ID: 25231636
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of age, diet, and type 2 diabetes on the development and FDG uptake of atherosclerotic plaques.
    Silvola JM; Saraste A; Laitinen I; Savisto N; Laine VJ; Heinonen SE; Ylä-Herttuala S; Saukko P; Nuutila P; Roivainen A; Knuuti J
    JACC Cardiovasc Imaging; 2011 Dec; 4(12):1294-301. PubMed ID: 22172786
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nuclear factor E2-related factor 2 deficiency impairs atherosclerotic lesion development but promotes features of plaque instability in hypercholesterolaemic mice.
    Ruotsalainen AK; Lappalainen JP; Heiskanen E; Merentie M; Sihvola V; Näpänkangas J; Lottonen-Raikaslehto L; Kansanen E; Adinolfi S; Kaarniranta K; Ylä-Herttuala S; Jauhiainen M; Pirinen E; Levonen AL
    Cardiovasc Res; 2019 Jan; 115(1):243-254. PubMed ID: 29917052
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased atherosclerotic lesion calcification in a novel mouse model combining insulin resistance, hyperglycemia, and hypercholesterolemia.
    Heinonen SE; Leppänen P; Kholová I; Lumivuori H; Häkkinen SK; Bosch F; Laakso M; Ylä-Herttuala S
    Circ Res; 2007 Nov; 101(10):1058-67. PubMed ID: 17872464
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vivo inhibition of nuclear factor of activated T-cells leads to atherosclerotic plaque regression in IGF-II/LDLR
    Blanco F; Heinonen SE; Gurzeler E; Berglund LM; Dutius Andersson AM; Kotova O; Jönsson-Rylander AC; Ylä-Herttuala S; Gomez MF
    Diab Vasc Dis Res; 2018 Jul; 15(4):302-313. PubMed ID: 29499628
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Absence of hyperlipidemia in LDL receptor-deficient mice having apolipoprotein B100 without the putative receptor-binding sequences.
    Johnson LA; Altenburg MK; Walzem RL; Scanga LT; Maeda N
    Arterioscler Thromb Vasc Biol; 2008 Oct; 28(10):1745-52. PubMed ID: 18617647
    [TBL] [Abstract][Full Text] [Related]  

  • 8. LDLR-/-ApoB100/100 mice with insulin-like growth factor II overexpression reveal a novel form of retinopathy with photoreceptor atrophy and altered morphology of the retina.
    Kinnunen K; Heinonen SE; Kalesnykas G; Laidinen S; Uusitalo-Järvinen H; Uusitalo H; Ylä-Herttuala S
    Mol Vis; 2013; 19():1723-33. PubMed ID: 23922490
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Imbalance of APOB Lipoproteins and Large HDL in Type 1 Diabetes Drives Atherosclerosis.
    Kothari V; Ho TWW; Cabodevilla AG; He Y; Kramer F; Shimizu-Albergine M; Kanter JE; Snell-Bergeon J; Fisher EA; Shao B; Heinecke JW; Wobbrock JO; Lee WL; Goldberg IJ; Vaisar T; Bornfeldt KE
    Circ Res; 2024 Jul; 135(2):335-349. PubMed ID: 38828596
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diabetes mellitus accelerates cartilaginous metaplasia and calcification in atherosclerotic vessels of LDLr mutant mice.
    Nguyen N; Naik V; Speer MY
    Cardiovasc Pathol; 2013; 22(2):167-75. PubMed ID: 22818582
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased Calcific Aortic Valve Disease in response to a diabetogenic, procalcific diet in the LDLr
    Scatena M; Jackson MF; Speer MY; Leaf EM; Wallingford MC; Giachelli CM
    Cardiovasc Pathol; 2018; 34():28-37. PubMed ID: 29539583
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Type 2 diabetes enhances arterial uptake of choline in atherosclerotic mice: an imaging study with positron emission tomography tracer ¹⁸F-fluoromethylcholine.
    Hellberg S; Silvola JM; Kiugel M; Liljenbäck H; Metsälä O; Viljanen T; Metso J; Jauhiainen M; Saukko P; Nuutila P; Ylä-Herttuala S; Knuuti J; Roivainen A; Saraste A
    Cardiovasc Diabetol; 2016 Feb; 15():26. PubMed ID: 26852231
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Expression profiles of lipid metabolism-related genes in liver of apoE(-/-)/LDLR(-/-) mice].
    Du HQ; Yin M; Ye HY; Shang YJ; Dai XD; Jing W; Zhang L; Xiao N; Li JF; Pan J
    Zhonghua Bing Li Xue Za Zhi; 2007 Nov; 36(11):751-5. PubMed ID: 18307880
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bempedoic Acid Lowers Low-Density Lipoprotein Cholesterol and Attenuates Atherosclerosis in Low-Density Lipoprotein Receptor-Deficient (
    Burke AC; Telford DE; Sutherland BG; Edwards JY; Sawyez CG; Barrett PHR; Newton RS; Pickering JG; Huff MW
    Arterioscler Thromb Vasc Biol; 2018 May; 38(5):1178-1190. PubMed ID: 29449335
    [TBL] [Abstract][Full Text] [Related]  

  • 15. LDL Receptor Regulates the Reverse Transport of Macrophage-Derived Unesterified Cholesterol via Concerted Action of the HDL-LDL Axis: Insight From Mouse Models.
    Cedó L; Metso J; Santos D; García-León A; Plana N; Sabate-Soler S; Rotllan N; Rivas-Urbina A; Méndez-Lara KA; Tondo M; Girona J; Julve J; Pallarès V; Benitez-Amaro A; Llorente-Cortes V; Pérez A; Gómez-Coronado D; Ruotsalainen AK; Levonen AL; Sanchez-Quesada JL; Masana L; Kovanen PT; Jauhiainen M; Lee-Rueckert M; Blanco-Vaca F; Escolà-Gil JC
    Circ Res; 2020 Aug; 127(6):778-792. PubMed ID: 32495699
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [18F]fluorodeoxyglucose uptake in atherosclerotic plaques is associated with reduced coronary flow reserve in mice.
    Uotila S; Silvola JM; Saukko P; Nuutila P; Heinonen SE; Ylä-Herttuala S; Roivainen A; Knuuti J; Saraste A
    J Ultrasound Med; 2014 Nov; 33(11):1941-8. PubMed ID: 25336481
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comprehensive MRI for the detection of subtle alterations in diastolic cardiac function in apoE/LDLR(-/-) mice with advanced atherosclerosis.
    Tyrankiewicz U; Skorka T; Orzylowska A; Jablonska M; Jasinski K; Jasztal A; Bar A; Kostogrys R; Chlopicki S
    NMR Biomed; 2016 Jun; 29(6):833-40. PubMed ID: 27146203
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biventricular adaptation to volume overload in mice with aortic regurgitation.
    Berry CJ; Miller JD; McGroary K; Thedens DR; Young SG; Heistad DD; Weiss RM
    J Cardiovasc Magn Reson; 2009 Aug; 11(1):27. PubMed ID: 19671155
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Exercise capacity and cardiac hemodynamic response in female ApoE/LDLR(-/-) mice: a paradox of preserved V'O2max and exercise capacity despite coronary atherosclerosis.
    Wojewoda M; Tyrankiewicz U; Gwozdz P; Skorka T; Jablonska M; Orzylowska A; Jasinski K; Jasztal A; Przyborowski K; Kostogrys RB; Zoladz JA; Chlopicki S
    Sci Rep; 2016 Apr; 6():24714. PubMed ID: 27108697
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High levels of IgM against methylglyoxal-modified apolipoprotein B100 are associated with less coronary artery calcification in patients with type 2 diabetes.
    Engelbertsen D; Anand DV; Fredrikson GN; Hopkins D; Corder R; Shah PK; Lahiri A; Nilsson J; Bengtsson E
    J Intern Med; 2012 Jan; 271(1):82-9. PubMed ID: 21668821
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.